Clearstead Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-464
Closed -$48K 1289
2022
Q2
$48K Hold
464
﹤0.01% 630
2022
Q1
$53K Hold
464
﹤0.01% 667
2021
Q4
$58K Hold
464
﹤0.01% 633
2021
Q3
$55K Hold
464
﹤0.01% 600
2021
Q2
$54K Hold
464
﹤0.01% 545
2021
Q1
$50K Buy
+464
New +$50.8K ﹤0.01% 544
2020
Q4
Sell
-456
Closed -$43K 994
2020
Q3
$43K Buy
+456
New +$42.7K ﹤0.01% 494

Other funds holding FXH

Clearstead Advisors's FXH Position: Q3 2022 in Review

Clearstead Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q3 2022, closing a stake of 464 shares — an estimated $48K sold.

Clearstead Advisors first reported a position in FXH in Q3 2020 and held it in 7 quarters. The position peaked at $58K in Q4 2021. 247 funds tracked by Wall St. Rank hold FXH as of Q3 2022.

  • Clearstead Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q3 2022 after selling out during the quarter.
  • Clearstead Advisors sold 464 First Trust Health Care AlphaDEX Fund shares in Q3 2022, an estimated $48K.
  • Clearstead Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q3 2020 and held it in 7 quarters.
  • Clearstead Advisors's First Trust Health Care AlphaDEX Fund position peaked at $58K in Q4 2021.
  • 247 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q3 2022.

Based on Clearstead Advisors's 13F filing for Q3 2022, filed 15 Nov 2022.